相似文献
1
Beyond medications: is pulmonary artery denervation the answer for pulmonary arterial hypertension?: PADN for PAH.
AsiaIntervention. 2022 Mar;8(1):14-15. doi: 10.4244/AIJ-E-22-00001. Epub 2022 Mar 15.
2
Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.
Circ Cardiovasc Interv. 2015 Nov;8(11):e002837. doi: 10.1161/CIRCINTERVENTIONS.115.002837.
3
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
JACC Cardiovasc Interv. 2022 Dec 12;15(23):2412-2423. doi: 10.1016/j.jcin.2022.09.013. Epub 2022 Sep 18.
4
Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
J Heart Lung Transplant. 2023 Aug;42(8):1140-1151. doi: 10.1016/j.healun.2023.03.015. Epub 2023 Mar 28.
5
Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
J Am Coll Cardiol. 2013 Sep 17;62(12):1092-1100. doi: 10.1016/j.jacc.2013.05.075. Epub 2013 Jul 10.
6
Pulmonary Artery Denervation: Update on Clinical Studies.
Curr Cardiol Rep. 2019 Sep 5;21(10):124. doi: 10.1007/s11886-019-1203-z.
7
Sympathetic innervation of canine pulmonary artery and morphometric and functional analysis in dehydromonocrotaline-induced models after pulmonary artery denervation.
Interact Cardiovasc Thorac Surg. 2020 Nov 1;31(5):708-717. doi: 10.1093/icvts/ivaa166.
8
Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension.
Oncotarget. 2016 Dec 20;8(33):54106-54114. doi: 10.18632/oncotarget.14031. eCollection 2017 Aug 15.
9
Pulmonary Artery Denervation as an Innovative Treatment for Pulmonary Hypertension With and Without Heart Failure.
Cardiol Rev. 2021;29(2):89-95. doi: 10.1097/CRD.0000000000000299.
10
Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
BMC Cardiovasc Disord. 2016 Oct 10;16(1):192. doi: 10.1186/s12872-016-0366-4.
本文引用的文献
1
Long-term mortality after pulmonary artery denervation stratified by baseline functional class in patients with pulmonary arterial hypertension: Long-term mortality after PADN stratified by functional class.
AsiaIntervention. 2022 Mar;8(1):58-68. doi: 10.4244/AIJ-D-21-00033. Epub 2022 Mar 15.
2
Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):704-718. doi: 10.1161/ATVBAHA.118.311992.
3
Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.
JACC Cardiovasc Interv. 2015 Dec 28;8(15):2013-2023. doi: 10.1016/j.jcin.2015.09.015.
4
Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
J Am Coll Cardiol. 2013 Sep 17;62(12):1092-1100. doi: 10.1016/j.jacc.2013.05.075. Epub 2013 Jul 10.
5
Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.
EuroIntervention. 2013 Jun 22;9(2):269-76. doi: 10.4244/EIJV9I2A43.
6
Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature.
Chest. 1980 Apr;77(4):525-30. doi: 10.1378/chest.77.4.525.
7
Fine structural study of the terminal effecror plexus, neuromuscular and intermuscular relationships in the pulmonary artery.
J Anat. 1968 Jun;103(Pt 1):49-63.
Zotero 插件